RO-0270253

N/A

Report date: 2025/01/15 16:59:51
NME

Base Information

Drug NameRO-0270253
Drug Alias NameRO0270253RO-0270253
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIntegrin alpha-4/beta-1 antagonistsIntegrin alpha-4/beta-7 antagonists
TargetsIntegrin alpha-4/beta-1Integrin alpha-4/beta-7
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoffmann-La Roche Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoffmann-La Roche Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A